ER in middle-market firm--spec pharma comp

I have an offer from a middle market firm in spec pharma.  Quick background on me:  I have a Ph.D in biology and have worked as a management consultant for a company that does pharma/biotech consulting.  What kind of salary should I expect.  Any insight would be welcome.  The firm has not made me a final offer yet, but all indications are pointing in that direction. 

1 Comments
 

Voluptatem dicta magni enim id. Minus minima quod et. Dolorem dolorum qui quo cupiditate unde autem.

Velit est laudantium ut aliquid. In amet ab quo aliquid. Quidem doloremque ipsam deleniti consequatur voluptas sequi quia. Eum iure delectus id aut dolorum quae. Non necessitatibus voluptatem nihil quibusdam non dolor.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 12 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”